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Abstract
Time to positivity (TTP) of blood cultures in patients with bacteraemia is considered to be a predictor of outcome for some bacterial
species. Two hundred and thirty-one patients with Klebsiella pneumoniae monomicrobial bacteraemia at a hospital from 1 January to 31
December 2007 were prospectively enrolled. TTP <7 h (46 patients, 19.9%) was associated with a higher Pittsburg bacteraemia score
(6.2 ± 5.5 vs. 3.7 ± 4.3, p 0.002), fewer non-fatal diseases by the McCabe classiﬁcation (39.1% vs. 64.9%, p 0.002), a higher percentage
of patients with liver cirrhosis, active malignancy, and chemotherapy within 3 months (28.3% vs. 11.9%, p 0.007; 28.3% vs. 14.6%,
p 0.031; 23.9% vs. 5.4%, p <0.001), more primary bacteraemia (45.7% vs. 22.2%, p 0.002), and a higher 30-day mortality rate (47.8% vs.
21.1%, p <0.001). Risk factors for 30-day mortality in the univariate analysis included higher Pittsburg bacteraemia score (5.8 ± 5.3 vs.
3.7 ± 4.3, p 0.002), primary bacteraemia (41.0% vs. 21.8%, p 0.004), TTP <7 h (36.1% vs. 14.1%, p <0.001), and the presence of active
malignancy (29.5% vs. 12.9%, p 0.004). In the multivariate analysis, higher Pittsburg bacteraemia score (OR 1.07; 95% CI 1.01–1.14),
TTP <7 h (OR 2.46; 95% CI 1.20–5.05) and active malignancy (OR 2.21; 95% CI 1.03–4.73) were the signiﬁcant factors associated
with 30-day mortality. In the Kaplan–Meier survival curve, short TTP was signiﬁcantly associated with mortality at all time-points after
admission. TTP of blood cultures, interpreted with a cut-off point of <7 h, in patients with K. pneumoniae bacteraemia can provide useful
prognostic information.
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Klebsiella pneumoniae is among the most common Gram-nega-
tive bacteria encountered by physicians worldwide. It is a
common hospital-acquired pathogen and a less frequently
community-acquired microorganism, causing urinary tract
infection, pneumonia, and intra-abdominal infection. In the past
decade, geographical differences have been recognized in the
spectrum of disease caused by K. pneumoniae, including a
preponderance of severe invasive disease in Taiwan [1,2]. A
distinctive syndrome, almost exclusive to Taiwan, has
emerged, in which liver abscess is accompanied by K. pneumo-
niae bacteraemia and typically occurs in patients with diabetes
mellitus. As compared with K. pneumoniae isolated from
patients with primary bacteraemia or non-abscess secondary
bacteraemia, abscess-forming organisms in Taiwan typically
have a virulent hypermucoviscosity phenotype [3] and may be
associated with metastatic infection, such as meningitis and
endophthalmitis [4].
Bloodstream infection (BSI) has been associated with
increased rates of hospitalization, length of stay, and hospital
costs [5–8]. A previous study suggested that the magnitude of
bacteraemia, caused by Gram-negative bacilli, as determined
by quantitative blood cultures may be related to mortality [9].
Given the strong relationship between the inoculum size and
the time to positivity (TTP), as assessed by automatic blood
culture devices [10], the latter may constitute a surrogate
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marker of the degree of bacteraemia and provide useful diag-
nostic and prognostic information [11].
Previous studies have shown that shorter TTP is associ-
ated with a signiﬁcantly greater mortality risk among patients
with Staphylococcus aureus bacteraemia [11,12]. Short TTP has
also been reported to be an independent predictor of fatal
outcome in patients with diverse-source Escherichia coli bac-
teraemia [13], and to be a marker of severe sepsis or shock
and meningitis in individuals with BSI caused by Streptococcus
pneumoniae [14]. TTP and the variables associated with it
have been evaluated for only a limited number of bacterial
species, and there has been only one study that has included
the relationship between TTP and clinical presentation of
K. pneumoniae bacteraemia [15]. We have investigated the
association between TTP in patients with K. pneumoniae bac-
teraemia and clinical outcome at a medical centre in Taiwan.
Materials and Methods
Study design
This was a prospective cohort study.
Setting and patients
This study was conducted at Far-Eastern Memorial Hospital,
a 1040-bed tertiary-care facility in northern Taiwan. Patients
with K. pneumoniae BSI were identiﬁed by central laboratory
personnel, who then contacted the researchers, from 1 Janu-
ary to 31 December 2007. Time to blood culture positivity
for each patient was retrieved from the hospital’s automated
blood culture instrument. Each patient was included only
once, at the time of the ﬁrst BSI. Patients aged less than
18 years, patients with polymicrobial bacteraemia, and
patients who were not admitted to the hospital were
excluded. The following data were recorded for each patient:
age, sex, underlying illness, location of care in the hospital,
neutropenia, plasma albumin, serum creatinine, severity of
illness classiﬁed by the McCabe Jackson criteria [16], and
severity of bacteraemia assessed by Pittsburg bacteraemia
score [17]. Malignancy with inactive status was not included
as an underlying illness. Outcome was assessed at 30 days
after blood samples were collected for culture. We evalu-
ated the appropriateness of empirical antibiotics after the
ﬁnal susceptibility results were reported, and patients were
recorded who had received antibiotics within the 12-h
period before blood samples were collected for culture.
TTP of blood cultures
At least two sets of blood samples, 10 mL each, were taken
from separate locations, and inoculated into aerobic and
anaerobic culture ﬂasks, which were incubated using the
BACTEC 9240 automated detection blood culture system
(Becton Dickinson Diagnostic Instrument Systems, Sparks,
MD, USA). All bottles were loaded when they were received
in the central laboratory. The BACTEC 9240 system contin-
uously monitors CO2 production every 10 min, and indicates
positivity by means of a ﬂuorescent signal. All bottles with
positive results were examined by Gram staining, and subcul-
tured. Species identiﬁcation was performed using biochemical
methods [18]. Susceptibility of isolates was determined by
the disk diffusion method, according to the criteria of the
CLSI [19]. TTP, deﬁned as the time from the start of incuba-
tion to the start of the alert signal (as documented by the
monitoring system), was recorded for each bottle of positive
blood cultures. For a patient with multiple sets of positive
blood cultures at approximately the same time, the shortest
TTP was used in the study.
Deﬁnitions
The clinical course and primary site of infection were deter-
mined from information supplied by primary-care physicians
and medical records. This diagnosis of the infection source
was based on clinical, bacteriological and radiological investi-
gations. Liver abscess was deﬁned as the coexistence of an
intrahepatic abscess revealed by ultrasonography or com-
puted tomography. Meningitis was deﬁned as culture of
K. pneumoniae from cerebrospinal ﬂuid. Catheter-related BSI
was deﬁned as a positive semiquantitative tip culture
(‡15 CFUs). Pneumonia was deﬁned as a positive culture of
K. pneumoniae in purulent sputum samples and the presence
of newly developed lung inﬁltrates, and urinary tract infection
(UTI) was deﬁned as a positive urine culture and pyuria. Bili-
ary tree infection was assumed when clinical ﬁndings were
compatible with this diagnosis. Intra-abdominal infection
included all infections at that site except BTI. Soft tissue
infection was deﬁned as clinical soft tissue inﬂammation. If
no focus could be identiﬁed, the bacteraemia was classiﬁed
as primary. We divided the study population into two groups
(patients with a short TTP (<7 h) and patients with a long
TTP (‡7 h)), on the basis of the ﬁndings of a previous study
of E. coli bacteraemia [13] and the result of univariate analy-
sis, which showed that a TTP cut-off point of <7 h carried a
higher OR than other cut-off values.
Statistical analysis
The demographic distribution and clinical characteristics
of patients with TTP <7 h and ‡7 h were compared using uni-
variate analysis. Means and standard deviations were
calculated for continuous variables. Percentages were used for
categorical variables. Univariate analysis was performed for
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associations between risk factors and 30-day mortality. Factors
associated with 30-day mortality according to univariate
analysis (p <0.1) were further evaluated with multivariate
logistic regression with forward selection. ORs and the corre-
sponding 95% CIs were calculated. Cumulative survival after
the day of blood sample collection until day 30 was calculated
by the Kaplan–Meier method. The mortality rates of grouped
TTP were depicted. Data were analysed using SPSS software
for Windows (Release 15.0; SPSS, Chicago, IL, USA).
Results
Study population and patient characteristics
A total of 231 patients with clinically signiﬁcant episodes of
BSI were identiﬁed among admissions to Far-Eastern Memo-
rial Hospital during the 1-year study period. Sixty-three
per cent of patients were identiﬁed in the emergency depart-
ment. The mean age was 61.7 ± 15.8 years, and 65% of
patients were male. Diabetes mellitus was the most common
underlying disease. The most frequent manifestation of BSI
was primary bacteraemia, followed by pneumonia and UTI.
Only six (2.3%) isolates of K. pneumoniae were extended-
spectrum b-lactamase-producing strains. The overall mortal-
ity rate was 32.5%.
TTP of blood cultures
The median TTP was 9.6 h (range, 1.3–128.0 h; mean,
13.1 h; standard deviation, 15.9 h). Associated risk factors
and outcomes of the two TTP groups are summarized in
Table 1. There was a signiﬁcant difference between the two
groups in the location of patients when the blood samples
were collected for culture, but no signiﬁcant differences in
age and sex. Patients with early positive cultures had a signif-
icantly higher Pittsburg bacteraemia score. No signiﬁcant dif-
ferences were found in the proportion of patients with
diabetes mellitus, end-stage renal disease, heart disease, alco-
hol use, steroid use, autoimmune disease, or recent surgery.
Patients with early positive cultures were more likely to have
liver cirrhosis or active malignancy, or to have received che-
motherapy within 3 months of enrolment. Primary bactera-
emia was more common in the TTP of the <7 h group than
in the TTP of the ‡7 h group. The proportion of extended-
spectrum b-lactamase-producing K. pneumoniae isolates was
signiﬁcantly higher in the group with short TTP.
Clinical outcomes
Patients with a short TTP had a higher mortality rate
than patients with a long TTP. The Kaplan–Meier survival
curve of patients with short or long TTP is shown in Fig. 1.
The mortality rates of grouped TTPs are shown in Fig. 2.
Univariate analysis revealed that higher Pittsburg bacteraemia
score, primary bacteraemia, active malignancy and TTP <7 h
were associated with 30-day mortality (Table 2). McCabe
non-fatal disease was a protective parameter. Multivariate
regression analysis revealed that higher Pittsburg bacteraemia
score, active malignancy and TTP <7 h were independent
predictors of death (respectively: OR 1.07, 95% CI
1.01–1.14; OR 2.21, 95% CI 1.20–5.05; OR 2.46, 95% CI
1.03–4.73) (Table 2).
Discussion
TTP of blood culture in patients with bacteraemia has been
associated with outcomes for a limited number of pathogens,
such as S. aureus [11,12], E. coli [13,20], Streptococcus pneumo-
niae [14], and Burkholderia pseudomallei [21]. This study is the
ﬁrst to investigate the association of clinical outcome and
TTP of blood cultures in patients with K. pneumoniae bacter-
aemia. In this investigation, nearly 20% of patients with
K. pneumoniae BSI exhibited a short TTP (<7 h), and TTP
‡7 h was demonstrated to be a signiﬁcant predictor of out-
come in the multivariate analysis. Patients with TTP <7 h
had at least a two-fold higher mortality rate than those with
TTP ‡7 h. In the Kaplan–Meier survival curve, short TTP
was signiﬁcantly associated with mortality at all time-points
after admission.
The TTP of blood cultures can be inﬂuenced by several
factors, including the volume of blood drawn, incubation con-
ditions, time from specimen collection to receipt in the labo-
ratory, the presence of growth inhibitors such as antibiotics,
and the concentrations of the organism within the blood
[22]. The volume of blood drawn was similar for all adult
patients in this study, and the incubation conditions were
stable because of the use of an automated system. A limita-
tion of this study was the failure to record the time that
elapsed between blood sample collection and loading into
the processing device. We assumed that the variations in this
process occurred randomly, and that the large number of
cases studied may have mitigated the inﬂuence of any individ-
ual variation. Recent antibiotic use was not a signiﬁcant fac-
tor for TTP of initial blood cultures in this study. Thus, the
difference in TTP was most probably strongly correlated
with the initial bacterial load.
A previous investigation [15] of 122 episodes of Klebsiella
spp. bacteraemia revealed the median TTP to be <10 h. The
present study of 231 patients with K. pneumoniae bactera-
emia gave similar results, with a median of 9.60 h. A previous
study evaluating TTP as a predictor of mortality in patients
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with E. coli bacteraemia applied <7 h as the cut-off point
[13], and showed that TTP <7 h correlated with fatal
outcome. In our study, we examined various cut-off times
for TTP and their relationship with 30-day mortality, and
showed that a cut-off at 7 h carried the highest OR. Regard-
ing underlying illnesses, neutropenia and liver cirrhosis have
been shown to be correlated with E. coli bacteraemia with
TTP <7 h [13]. In a study of S. aureus bacteraemia [12], all
patients with neutropenia had a short TTP of <12 h. Marti-
nez et al. also reported [15] that liver cirrhosis and neutro-
penia were associated with faster growth. The present
investigation revealed that patients with liver cirrhosis, active
malignancy, or chemotherapy within 3 months were more
likely to have a TTP of <7 h. Moreover, severe underlying ill-
ness indicated by the McCabe classiﬁcation or higher Pitts-
burg bacteraemia scores were associated with shorter TTP.
These ﬁndings are in agreement with a previous study of
patients with S. aureus bacteraemia, in which short TTP was
associated with more severe acute illness [11]. All of these
ﬁndings suggest that host factors may play an important role
in the quantity of microorganisms in the blood in patients
with bacteraemia.
TABLE 1. Risk factors and outcomes associated with time to positivity (TTP) of blood cultures (<7 or ‡7 h) in Klebsella
pneumoniae bacteraemia
Variable
TTP <7 h TTP ‡7 h
OR 95% CI p-value(n = 46) (n = 185)
Age (years) 58.1 ± 11.7 62.6 ± 16.5 0.98 0.96–1.00 0.084
Sex (M/F) 33/13 117/68 1.48 0.73–3.00 0.282
Location of patient
Emergency department 15 (32.6%) 123 (66.5%) 0.24 0.12–0.49 <0.001
Ward 23 (50.0%) 38 (20.5%) – – –
Intensive-care unit 8 (17.4%) 24 (13.0%) – – –
Severity of illness (McCabe)
Non-fatal disease 18 (39.1%) 120 (64.9%) 0.35 0.18–0.68 0.002
Ultimately fatal disease 20 (43.5%) 47 (25.4%) – – –
Rapidly fatal disease 8 (17.4%) 18 (9.7%) – – –
Pittsburg bacteraemia score 6.2 ± 5.5 3.7 ± 4.3 1.11 1.04–1.18 0.002
Underlying illness/condition
Diabetes mellitus 17 (36.9%) 72 (38.9%) 0.92 0.47–1.79 0.807
End-stage renal disease 1 (2.2%) 9 (4.9%) 0.44 0.05–3.52 0.435
Heart disease 8 (17.4%) 38 (20.5%) 0.81 0.35–1.89 0.633
Stroke 6 (13.0%) 24 (13.0%) 1.01 0.39–2.63 0.990
Active malignancy 13 (28.3%) 27 (14.6%) 2.31 1.08–4.93 0.031
Liver cirrhosis 13 (28.3%) 22 (11.9%) 2.92 1.34–6.37 0.007
Alcohol 12 (26.1%) 36 (19.5%) 1.46 0.69–3.10 0.323
Steroid use 4 (8.7%) 7 (3.8%) 2.42 0.68–8.66 0.173
Chemotherapy within 3 months 11 (23.9%) 10 (5.4%) 5.50 2.17–13.94 <0.001
Neutropenia 4 (8.7%) 5 (2.7%) 3.43 0.88–13.32 0.075
Surgery (<3 months) 16 (34.8%) 42 (22.7%) 1.82 0.90–3.65 0.094
Creatinine (mg/dl) 2.1 ± 1.7 1.8 ± 1.9 1.09 0.93–1.27 0.303
Albumina (g/dl) 2.7 ± 0.7 2.8 ± 0.6 0.81 0.44–1.49 0.500
Type of infection
Catheter-related 3 (6.5%) 3 (1.6%) 4.23 0.83–21.70 0.084
Soft tissue infection 2 (4.3%) 1 (0.5%) 8.36 0.74–94.33 0.086
Primary bacteraemia 21 (45.7%) 41 (22.2%) 2.95 1.50–5.80 0.002
Respiratory tract infection 5 (10.9%) 37 (20.0%) 0.49 0.18–1.32 0.158
Urinary tract infection 6 (13.0%) 31 (16.8%) 0.75 0.29–1.91 0.540
Biliary tract infection 4 (8.7%) 29 (15.7%) 0.51 0.17–1.54 0.233
Meningitis 0 (0%) 3 (1.6%) – – 0.999
Intra-abdominal infection 3 (6.5%) 11 (5.9%) 1.10 0.30–4.13 0.884
Other 0 (0%) 2 (1.1%) – – 0.999
Liver abscess 2 (4.3%) 29 (15.7%) 0.24 0.06–1.07 0.061
Endophthalmitis 0 (0%) 2 (1.1%) 0.999
Mortality
Day 3 15 (32.6%) 22 (11.9%) 3.59 1.68–7.67 <0.001
Day 7 16 (34.8%) 26 (14.1%) 3.26 1.56–6.80 0.002
Day 14 18 (39.1%) 32 (17.3%) 3.07 1.52–6.22 0.002
Day 30 22 (47.8%) 39 (21.1%) 3.43 1.74–6.76 <0.001
Overall 23 (50.0%) 52 (28.1%) 2.56 1.32–4.95 0.005
ESBL producer 4 (8.7%) 2 (0.5%) 8.71 1.55–49.16 0.014
Effective empirical antibiotic 39 (84.8%) 176 (95.1%) 0.29 0.10–0.81 0.019
Antibiotic given prior to blood culture 6 (13.0%) 19 (10.3%) 1.31 0.49–3.49 0.589
ESBL, extended-spectrum b-lactamase.
aFor TTP <7 h, 34 cases with available albumin level; for TTP ‡7 h, 113 cases with available albumin level.
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The correlation between TTP and source of infection
remains unclear. In a study of patients with S. aureus bactera-
emia, a shorter TTP was associated with endovascular infec-
tion [12]. UTI was correlated with longer TTP in a study of
E. coli bacteraemia [13]. For pneumococcal infections, menin-
gitis was correlated with shorter TTP [14]. Furthermore, a
previous study suggested that catheter-related infection
might cause a shorter TTP [10]. In our study, only six
patients had a diagnosis of catheter-related BSI, so vascular
catheterization did not play a major role in determining TTP.
Liver abscess caused by K. pneumoniae is a special concern in
Taiwan. In this study, we found that TTP was shorter in
patients with primary bacteraemia, but not in those with
liver abscess. In contrast, patients with liver abscess showed
a trend towards longer TTP. This may have been due to dif-
ferences in host immunity, with those who developed liver
abscess having relatively good immunity as compared with
those with primary bacteraemia.
This study had several limitations. We did not record the
duration of illness before blood samples were collected for
culture, which might have an important inﬂuence on bactera-
emia severity. The timing of blood samples collection is
another major issue. Whether bacteraemia is a continuous
condition remains unclear. Evaluations of the interval between
the presentation of chills and the collection and culture of
blood specimens are inherently inexact. Whether a shorter
interval between these events is associated with a shorter
TTP is not known, but in this study, we demonstrated that
FIG. 1. Kaplan–Meier survival curves of 231
patients with Klebsiella pneumoniae bacteraemia
(grouped by time to positivity (TTP) of blood
culture <7 h and ‡7 h, log rank test,
p <0.001).
FIG. 2. Mortality rates of patients with Klebsi-
ella pneumoniae bacteraemia according to the
indicated category of time to positivity of
blood cultures.
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TTPs of blood samples collected in the emergency department
were generally longer than those of samples collected nosoco-
mially. Patients infected with ESBL producers tended to have
shorter TTPs in this study, but the number was too small else-
where in the hospital to allow conclusions to be drawn. In
addition, in view of the special epidemiology of K. pnuemoniae
in Taiwan, whether the result can be generalized to other
countries needs further investigation.
In conclusion, a short TTP in patients with K. pneumoniae
bacteraemia was associated with a signiﬁcantly greater mor-
tality risk. TTP data are easily obtainable in-hospital and can
provide prognostic information for patients with K. pneumo-
niae bacteraemia.
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